Covaxin side-effects: A study conducted by the Banaras Hindu University (BHU) stated that nearly one-third of 926 Covaxin ...

People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of ...

Nearly 30 percent people who took Bharat Biotech’s COVID-19 vaccine – Covaxin – experienced ‘adverse events of special ...

As the MvPI is an important programme for reporting adverse events, coordinated analysis, etc related to medical devices, including in-vitro diagnostic devices, it is suggested that all licence ...

CONCURRENT prenatal cannabis and nicotine use has been linked to adverse maternal and neonatal outcomes, in research ...

Tiffany Bostwick, P.A., discussed the importance of communication and education around adverse effects for both oncology ...

Officials with the California Department of Public Health issued a warning Wednesday to consumers seeking Botox injections ...

SRINAGAR: Nearly one-third of 926 individuals who received Bharat Biotech’s anti-Covid vaccine Covaxin reported ‘adverse ...

Merck & Co. has bailed early on a phase 3 test of the anti-TIGIT antibody vibostolimab after a high rate of discontinuations ...

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, ...

Nearly one-third of the individuals who received Bharat Biotech’s anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study ...

CDSCO calls for timely reporting of adverse events related to medical devices to MvPI: Gireesh Babu, New Delhi Friday, May 17, 2024, 08:00 Hrs [IST] The Central Drugs Standard Con ...